Health Policy Medicare Pharmaceuticals Telemedicine 
Health Populi
MARCH 11, 2021
[Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.
Health Populi
JUNE 24, 2021
The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. spends on NASA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
MAY 20, 2020
Payors, both commercial and public sector (Medicare, Medicaid), have relaxed rules and regulations for telehealth across platforms (from purpose-built telemedicine programs to HIPAA-relaxed approvals for using FaceTime, Zoom, and other commercial channels), and have various plans to pay for virtual care visits between clinicians and patients.
Healthcare IT News - Telehealth
JANUARY 4, 2021
Pharmaceutical companies will be collaborating extensively for manufacturing, supply chain requirements, post surveillance studies as well as storage. Reforms in national health policies and budget constraints will increase the appeal and appetite towards Opex business models.
Henry Kotula
JUNE 23, 2020
In the short-term emergency healthcare packages have included increasing patient access to medicines, waiving co-pays, relaxing prior approval requirements and increasing telemedicine services. The commercial healthcare market is likely to contract and demand for Medicare/Medicaid will increase. But longer term?
Henry Kotula
JULY 1, 2019
Payers and employers are aiming to grow the role of telemedicine as employees grow more comfortable with it, especially if out-of-pocket costs are lower and the quality doesn’t suffer. The trend has implications for employers, payers, providers and even pharmaceutical and life science companies. WHAT ELSE YOU SHOULD KNOW.
Henry Kotula
JULY 28, 2023
The series covered broad issues related to the healthcare workforce, economy, and health policy, and highlighted internal industry changes and trends in service delivery, quality, and equity. As we noted, this was due to such factors as higher-than-normal expenses for staff, supplies, and pharmaceuticals and lower revenues.
Expert insights. Personalized for you.
245 
Let's personalize your content